Abbott director awarded 231 stock equivalent units
Abbott Laboratories director Kevin T. Conroy reported a compensation-related award of stock equivalent units.
Rhea-AI Filing Summary
Abbott Laboratories director Kevin T. Conroy reported a compensation-related award of stock equivalent units. On this Form 4, he acquired 231 stock equivalent units at a reference price of $90.74 per unit, bringing his total reported holdings of this derivative instrument to 231 units.
The award represents director fees credited to a stock equivalent unit account under a grantor trust established by the director. These units track Abbott common share performance and are paid in cash, generally at age 65 or upon retirement from the board, rather than involving open-market share purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 231 shares
Grant/Award
1 txn
Insider
Conroy Kevin T
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Equivalent Units | 231 | $90.74 | $21K |
Holdings After Transaction:
Stock Equivalent Units — 231 contracts (Direct)
Footnotes (1)
- F1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.
Key Figures
Stock equivalent units granted: 231 units
Reference price per unit: $90.74 per unit
Total stock equivalent units after grant: 231 units
+2 more
5 metrics
Stock equivalent units granted
231 units
Grant of stock equivalent units on June 30, 2026
Reference price per unit
$90.74 per unit
Valuation of stock equivalent unit grant
Total stock equivalent units after grant
231 units
Holdings following reported transaction
Underlying common shares
231 shares
Underlying Abbott common shares linked to units
Conversion or exercise price
$0.00
Reported conversion/exercise price for the units
Key Terms
Stock Equivalent Units, grantor trust, director fees, underlying security
4 terms
Stock Equivalent Units financial
"security_title: "Stock Equivalent Units" and footnote explaining the units"
Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.
grantor trust financial
"under a grantor trust established by the director and paid, in cash"
A grantor trust is a legal arrangement where the person who puts assets into the trust keeps enough control or rights that, for tax and legal purposes, those assets are treated as still belonging to that person. For investors, that matters because income, gains and losses generated by the trust typically flow through to the grantor (or directly to investors) for tax reporting and distributions, affecting after-tax returns and cash flow predictability — think of it like a mailbox that forwards all the mail back to the sender rather than holding it inside.
director fees financial
"Director fees credited to a stock equivalent unit account under a grantor trust"
underlying security financial
"underlying_security_title: "Common Shares" and underlying_security_shares: "231.0000""
FAQ
What insider transaction did Abbott Laboratories (ABT) report for Kevin T. Conroy?
Abbott Laboratories director Kevin T. Conroy reported an award of 231 stock equivalent units. These units represent deferred director fees tied to Abbott’s share performance rather than an open-market stock purchase or sale, and are settled in cash at a future date.
Is Kevin T. Conroy’s Form 4 transaction in ABT stock a buy or sell?
The Form 4 shows an acquisition coded as a grant or award, not an open-market buy or sell. Conroy received 231 stock equivalent units as director compensation, with no immediate trading of Abbott common shares reported in this filing.
How are Kevin T. Conroy’s stock equivalent units in Abbott (ABT) structured?
The 231 stock equivalent units are credited to a stock equivalent unit account under a grantor trust established by the director. They earn the same return as if invested in Abbott stock, but are paid out in cash, generally at age 65 or board retirement.
What is the reference price for Kevin T. Conroy’s stock equivalent unit grant at Abbott (ABT)?
The reported reference price for the grant is $90.74 per stock equivalent unit. This price is used to value the 231-unit director fee award, which tracks Abbott’s share performance but does not involve immediate issuance of common shares.
How many Abbott (ABT) stock equivalent units does Kevin T. Conroy hold after this transaction?
After the reported grant, Kevin T. Conroy’s total holding of this derivative instrument is 231 stock equivalent units. Each unit is linked to an equivalent number of underlying Abbott common shares for return purposes, but is ultimately settled in cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
